Selected research
Market Structure
Global Hormonal Contraceptive Implant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Hormonal Contraceptive Implant market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Hormonal Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Hormonal Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Hormonal Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Hormonal Contraceptive Implant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Hormonal Contraceptive Implant include Merck, Shanghai Dahua Pharmaceuticals, Bayer HealthCare and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Hormonal Contraceptive Implant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hormonal Contraceptive Implant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hormonal Contraceptive Implant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hormonal Contraceptive Implant market size, projected growth trends, production technologies, key applications, and end-use industries.
Hormonal Contraceptive Implant Segment by Company
Merck
Shanghai Dahua Pharmaceuticals
Bayer HealthCare
Allergan
Hormonal Contraceptive Implant Segment by Type
Levonorgestrel Contraceptive Implants
Etonogestrel Contraceptive Implants
Hormonal Contraceptive Implant Segment by Application
Hospitals
Clinics
Others
Hormonal Contraceptive Implant Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hormonal Contraceptive Implant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hormonal Contraceptive Implant and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hormonal Contraceptive Implant.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hormonal Contraceptive Implant market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hormonal Contraceptive Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hormonal Contraceptive Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hormonal Contraceptive Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel Contraceptive Implants
- Etonogestrel Contraceptive Implants
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Merck
- Shanghai Dahua Pharmaceuticals
- Bayer HealthCare
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hormonal Contraceptive Implant Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hormonal Contraceptive Implant Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hormonal Contraceptive Implant Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hormonal Contraceptive Implant Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hormonal Contraceptive Implant Market Dynamics
- 2.1 Hormonal Contraceptive Implant Industry Trends
- 2.2 Hormonal Contraceptive Implant Industry Drivers
- 2.3 Hormonal Contraceptive Implant Industry Opportunities and Challenges
- 2.4 Hormonal Contraceptive Implant Industry Restraints
3 Hormonal Contraceptive Implant Market by Manufacturers
- 3.1 Global Hormonal Contraceptive Implant Revenue by Manufacturers (2021-2026)
- 3.2 Global Hormonal Contraceptive Implant Sales by Manufacturers (2021-2026)
- 3.3 Global Hormonal Contraceptive Implant Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hormonal Contraceptive Implant Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hormonal Contraceptive Implant Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hormonal Contraceptive Implant Manufacturers, Product Type & Application
- 3.7 Global Hormonal Contraceptive Implant Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hormonal Contraceptive Implant Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hormonal Contraceptive Implant Players Market Share by Revenue in 2025
- 3.8.3 2025 Hormonal Contraceptive Implant Tier 1, Tier 2, and Tier 3
4 Hormonal Contraceptive Implant Market by Type
- 4.1 Hormonal Contraceptive Implant Type Introduction
- 4.1.1 Levonorgestrel Contraceptive Implants
- 4.1.2 Etonogestrel Contraceptive Implants
- 4.2 Global Hormonal Contraceptive Implant Sales by Type
- 4.2.1 Global Hormonal Contraceptive Implant Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hormonal Contraceptive Implant Sales by Type (2021-2032)
- 4.2.3 Global Hormonal Contraceptive Implant Sales Market Share by Type (2021-2032)
- 4.3 Global Hormonal Contraceptive Implant Revenue by Type
- 4.3.1 Global Hormonal Contraceptive Implant Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hormonal Contraceptive Implant Revenue by Type (2021-2032)
- 4.3.3 Global Hormonal Contraceptive Implant Revenue Market Share by Type (2021-2032)
5 Hormonal Contraceptive Implant Market by Application
- 5.1 Hormonal Contraceptive Implant Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Hormonal Contraceptive Implant Sales by Application
- 5.2.1 Global Hormonal Contraceptive Implant Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hormonal Contraceptive Implant Sales by Application (2021-2032)
- 5.2.3 Global Hormonal Contraceptive Implant Sales Market Share by Application (2021-2032)
- 5.3 Global Hormonal Contraceptive Implant Revenue by Application
- 5.3.1 Global Hormonal Contraceptive Implant Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hormonal Contraceptive Implant Revenue by Application (2021-2032)
- 5.3.3 Global Hormonal Contraceptive Implant Revenue Market Share by Application (2021-2032)
6 Global Hormonal Contraceptive Implant Sales by Region
- 6.1 Global Hormonal Contraceptive Implant Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hormonal Contraceptive Implant Sales by Region (2021-2032)
- 6.2.1 Global Hormonal Contraceptive Implant Sales by Region (2021-2026)
- 6.2.2 Global Hormonal Contraceptive Implant Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hormonal Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hormonal Contraceptive Implant Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hormonal Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hormonal Contraceptive Implant Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hormonal Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hormonal Contraceptive Implant Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hormonal Contraceptive Implant Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hormonal Contraceptive Implant Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hormonal Contraceptive Implant Revenue by Region
- 7.1 Global Hormonal Contraceptive Implant Revenue by Region
- 7.1.1 Global Hormonal Contraceptive Implant Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hormonal Contraceptive Implant Revenue by Region (2021-2026)
- 7.1.3 Global Hormonal Contraceptive Implant Revenue by Region (2027-2032)
- 7.1.4 Global Hormonal Contraceptive Implant Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hormonal Contraceptive Implant Revenue (2021-2032)
- 7.2.2 North America Hormonal Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hormonal Contraceptive Implant Revenue (2021-2032)
- 7.3.2 Europe Hormonal Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hormonal Contraceptive Implant Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hormonal Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hormonal Contraceptive Implant Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hormonal Contraceptive Implant Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Merck
- 8.1.1 Merck Company Information
- 8.1.2 Merck Business Overview
- 8.1.3 Merck Hormonal Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Merck Hormonal Contraceptive Implant Product Portfolio
- 8.1.5 Merck Recent Developments
- 8.2 Shanghai Dahua Pharmaceuticals
- 8.2.1 Shanghai Dahua Pharmaceuticals Company Information
- 8.2.2 Shanghai Dahua Pharmaceuticals Business Overview
- 8.2.3 Shanghai Dahua Pharmaceuticals Hormonal Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shanghai Dahua Pharmaceuticals Hormonal Contraceptive Implant Product Portfolio
- 8.2.5 Shanghai Dahua Pharmaceuticals Recent Developments
- 8.3 Bayer HealthCare
- 8.3.1 Bayer HealthCare Company Information
- 8.3.2 Bayer HealthCare Business Overview
- 8.3.3 Bayer HealthCare Hormonal Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Bayer HealthCare Hormonal Contraceptive Implant Product Portfolio
- 8.3.5 Bayer HealthCare Recent Developments
- 8.4 Allergan
- 8.4.1 Allergan Company Information
- 8.4.2 Allergan Business Overview
- 8.4.3 Allergan Hormonal Contraceptive Implant Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Allergan Hormonal Contraceptive Implant Product Portfolio
- 8.4.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hormonal Contraceptive Implant Value Chain Analysis
- 9.1.1 Hormonal Contraceptive Implant Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hormonal Contraceptive Implant Production Mode & Process
- 9.2 Hormonal Contraceptive Implant Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hormonal Contraceptive Implant Distributors
- 9.2.3 Hormonal Contraceptive Implant Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst